Nasser Mikhail

1.3k total citations
59 papers, 943 citations indexed

About

Nasser Mikhail is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Nasser Mikhail has authored 59 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Endocrinology, Diabetes and Metabolism, 17 papers in Surgery and 13 papers in Molecular Biology. Recurrent topics in Nasser Mikhail's work include Diabetes Treatment and Management (22 papers), Metabolism, Diabetes, and Cancer (11 papers) and Diabetes Management and Research (7 papers). Nasser Mikhail is often cited by papers focused on Diabetes Treatment and Management (22 papers), Metabolism, Diabetes, and Cancer (11 papers) and Diabetes Management and Research (7 papers). Nasser Mikhail collaborates with scholars based in United States and Canada. Nasser Mikhail's co-authors include Michael L. Tuck, Soma Wali, Michael S. Golub, Irwin Ziment, Dennis Cope, Mitchell S. Cappell, Johanne Tremblay, Pavel Hamet, Noboru Fukuda and Daniel Friedman and has published in prestigious journals such as The American Journal of Medicine, Progress in Cardiovascular Diseases and Endocrinology and Metabolism Clinics of North America.

In The Last Decade

Nasser Mikhail

52 papers receiving 884 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nasser Mikhail United States 18 453 265 201 172 107 59 943
Hylton V. Joffe United States 16 431 1.0× 313 1.2× 105 0.5× 279 1.6× 115 1.1× 32 1.3k
Valeria Cernaro Italy 21 197 0.4× 175 0.7× 187 0.9× 104 0.6× 88 0.8× 87 1.2k
John A. Seibel United States 6 507 1.1× 234 0.9× 133 0.7× 129 0.8× 97 0.9× 7 950
Amit D. Raval United States 21 332 0.7× 169 0.6× 125 0.6× 156 0.9× 66 0.6× 80 1.3k
Zahra Kashi Iran 18 389 0.9× 157 0.6× 145 0.7× 47 0.3× 44 0.4× 98 957
Giuseppe Lisco Italy 18 407 0.9× 91 0.3× 189 0.9× 67 0.4× 85 0.8× 74 1.0k
Frederick C. Whittier United States 20 341 0.8× 243 0.9× 184 0.9× 139 0.8× 76 0.7× 51 1.5k
D. Simon France 18 623 1.4× 89 0.3× 279 1.4× 82 0.5× 91 0.9× 54 1.0k
Gerard Boran Ireland 15 469 1.0× 151 0.6× 174 0.9× 125 0.7× 29 0.3× 57 1.2k
Stein Vaaler Norway 20 712 1.6× 201 0.8× 158 0.8× 107 0.6× 75 0.7× 55 1.3k

Countries citing papers authored by Nasser Mikhail

Since Specialization
Citations

This map shows the geographic impact of Nasser Mikhail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nasser Mikhail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nasser Mikhail more than expected).

Fields of papers citing papers by Nasser Mikhail

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nasser Mikhail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nasser Mikhail. The network helps show where Nasser Mikhail may publish in the future.

Co-authorship network of co-authors of Nasser Mikhail

This figure shows the co-authorship network connecting the top 25 collaborators of Nasser Mikhail. A scholar is included among the top collaborators of Nasser Mikhail based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nasser Mikhail. Nasser Mikhail is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mikhail, Nasser. (2024). Appraisal of Olezarsen for Treatment of Hypertriglyceridemia. 5(1). 41–48. 1 indexed citations
2.
Mikhail, Nasser. (2024). Aldosterone Synthase Inhibitors for Treatment of Hypertension and Chronic Kidney Disease. 6(1). 8–12. 3 indexed citations
3.
4.
Mikhail, Nasser, et al.. (2022). Iatrogenic Cushing’s Syndrome Caused by Adulteration of a Health Product with Dexamethasone. 6–9. 5 indexed citations
5.
Mikhail, Nasser, Soma Wali, & Arleen F. Brown. (2021). Ethnic Disparities in Diabetes. Endocrinology and Metabolism Clinics of North America. 50(3). 475–490. 17 indexed citations
6.
Mikhail, Nasser & Soma Wali. (2021). Safety of Dipeptidyl Peptidase-4 Inhibitors in COVID-19: An Update. 1–4. 1 indexed citations
7.
Mikhail, Nasser & Soma Wali. (2020). Ethnic Disparities in Knowledge of COVID-19. 5(3). 1 indexed citations
8.
Mikhail, Nasser & Soma Wali. (2020). Prognostic value of hypocalcemia in COVID-19. 7(3).
9.
Mikhail, Nasser. (2020). Update on Inclisiran for Treatment of Hypercholesterolemia. 1–3. 1 indexed citations
10.
Mikhail, Nasser. (2016). Safety of Technosphere Inhaled Insulin. Current Drug Safety. 12(1). 27–31. 6 indexed citations
11.
Mikhail, Nasser. (2015). Use of Sodium-Glucose Cotransporter Type 2 Inhibitors in Older Adults with Type 2 Diabetes Mellitus. Southern Medical Journal. 108(2). 91–96. 18 indexed citations
12.
Mikhail, Nasser. (2014). Place of sodium-glucose co-transporter type 2 inhibitors for treatment of type 2 diabetes. World Journal of Diabetes. 5(6). 854–854. 41 indexed citations
13.
Mikhail, Nasser. (2013). Management of Hyperglycemia in Hospitalized Noncritical Patients. Southern Medical Journal. 106(3). 238–246. 1 indexed citations
14.
Mikhail, Nasser. (2010). Is Liraglutide A Useful Addition to Diabetes Therapy?. Endocrine Practice. 16(6). 1028–1037. 3 indexed citations
15.
Mikhail, Nasser. (2008). Incretin mimetics and dipeptidyl peptidase 4 inhibitors in clinical trials for the treatment of type 2 diabetes. Expert Opinion on Investigational Drugs. 17(6). 845–853. 49 indexed citations
16.
Mikhail, Nasser. (2006). Is Exenatide A Useful Addition to Diabetes Therapy?. Endocrine Practice. 12(3). 307–314. 3 indexed citations
17.
Mikhail, Nasser, Soma Wali, & Irwin Ziment. (2004). Use of Alternative Medicine Among Hispanics. The Journal of Alternative and Complementary Medicine. 10(5). 851–859. 61 indexed citations
18.
Mikhail, Nasser & Dennis Cope. (2004). Visual Vignette. Endocrine Practice. 10(2). 165–165. 4 indexed citations
19.
Mikhail, Nasser. (2004). Methimazole-induced Cholestatic Jaundice. Southern Medical Journal. 97(2). 178–182. 37 indexed citations
20.
Mikhail, Nasser, et al.. (1999). Ionized Serum Magnesium in Type 2 Diabetes Mellitus. Southern Medical Journal. 92(12). 1162–1166. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hylton V. Joffe Breakdown of academic impact, for papers by Valeria Cernaro Breakdown of academic impact, for papers by John A. Seibel Breakdown of academic impact, for papers by Amit D. Raval Breakdown of academic impact, for papers by Zahra Kashi Breakdown of academic impact, for papers by Giuseppe Lisco Breakdown of academic impact, for papers by Frederick C. Whittier Breakdown of academic impact, for papers by D. Simon Breakdown of academic impact, for papers by Gerard Boran Breakdown of academic impact, for papers by Stein Vaaler
Rankless by CCL
2026